Skip to content
Review

Single-cell insights into drug response and resistance in inflammatory bowel disease: cellular hallmarks and precision therapy.

Sep 2026 · Journal of Crohn's & Colitis · Vol 20 9 · 0 citations
Medicine

TL;DR

These findings support a cellular ecosystem framework for understanding therapeutic response and resistance in inflammatory bowel disease and suggest that therapeutic efficacy may depend on the capacity to remodel multicellular communication networks rather than simply neutralizing individual molecular targets.

View source

Similar papers

Review Sep 2026

Immune-Epidermal Dual Targeting in Psoriasis: Emerging Technologies and Translational Therapeutic Strategies.

Although immune-targeted therapies, particularly agents targeting the IL-23/IL-17 axis, have markedly improved short-term disease control in psoriasis, inadequate responses in a subset of patients and relapse after treatment discontinuation remain unresolved challenges. One possible reason is that immune-centered thera...

Mei-Jun Liu, Pin-Zhi Dong, Cong Yang et al. · 0 citations
Review Open access Sep 2026

Spatial multi-omics-guided drug development in inflammatory bowel disease: from mucosal immune niches to precision therapy

Crohn’s disease and ulcerative colitis are now treated with an expanding set of biologics and small molecules, yet treatment selection remains largely empirical. Primary non-response, secondary loss of response, incomplete mucosal healing, fibrostenosis, and fistulizing disease show that conventional clinical, endoscop...

Hai Wang, Xiao-Long Zhao, Jie Yang · 0 citations
Review Oct 2026

The Impact of the Tumor Microenvironment on Immune Checkpoint Inhibitor Resistance in Prostate Cancer: Mechanistic Insights and Therapeutic Strategies.

While immune checkpoint inhibitors (ICIs) have revolutionized the treatment landscape for melanoma and lung cancer, their efficacy in prostate cancer (PCa) remains limited. This therapeutic resistance is linked in part to the "cold" immunophenotype of PCa, which is orchestrated by a highly immunosuppressive tumor micro...

Si-Yu Zhou, Yi-Fan Bi, Zi-Yi Xiong et al. · 0 citations
Review Oct 2026

Therapy-Associated Myeloid Niches as Spatial Drivers of Cancer Treatment Resistance and Targets for Mechanism-Matched Intervention.

Tumor drug resistance is still the core obstacle limiting the long-term benefit of modern anticancer therapy, especially in the context of treatment tolerance, persistence of minimal residual disease (MRD) and recurrence after treatment. Increasing evidence has shown that therapy-associated myeloid niches can involve c...

Ting Li, Yan-Xia Lin, Q. Gang et al. · 0 citations
Review Open access Sep 2026

Revisiting the immunosuppressive microenvironment in hepatocellular carcinoma: a functional taxonomy of immune cells and therapeutic targeting.

This review provides an integrated and conceptual analysis of the HCC immune landscape, delineating the mechanistic drivers underlying immune suppression, summarizes current immune-based classification frameworks, and dissects the context-dependent functions of key immune cell populations in tumor progression.

Jia-Qian Zhang, Si-Wen Li, Xiang-Long Ma et al. · 1 citation

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.